Evidence map›Paper›PMID 41118570›Full record

ArticleNucleic acids research2025

Single-colony resolution of CRISPR-Cas adaptation in E. coli reveals altered spacer-source bias during solid-phase growth.

Jack Braithwaite, Christopher Cannon, Ronald Chalmers, Harry Edwards

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jack BraithwaiteSchool of Life Sciences, University of Nottingham, Queens Medical Centre, Nottingham NG7 2UK, United Kingdom.
Christopher CannonSchool of Life Sciences, University of Nottingham, Queens Medical Centre, Nottingham NG7 2UK, United Kingdom.
Ronald ChalmersSchool of Life Sciences, University of Nottingham, Queens Medical Centre, Nottingham NG7 2UK, United Kingdom.
Harry EdwardsSchool of Life Sciences, University of Nottingham, Queens Medical Centre, Nottingham NG7 2UK, United Kingdom.ORCID 0000-0001-5121-8972

Funding

Leverhulme Trust RPG-2020-079University of Nottingham
6 · The paper itself

Abstract

CRISPR-Cas systems provide adaptive immunity by integrating short DNA fragments from mobile genetic elements into host arrays. While the core biochemical mechanism of adaptation is well defined, its modulation by physiological contexts is less well understood. Here, we present a visual papillation assay that enables single-colony detection of CRISPR-Cas adaptation in Escherichia coli. Spacer acquisition restores the reading frame of a disrupted lacZ gene, forming blue papillae on lactose X-gal plates. The assay is semi-quantitative, highly sensitive, capable of detecting single events among 109 cells, and responds predictably to Cas1-Cas2 expression levels. Spacer mapping revealed a major shift in source bias: in liquid culture, 64% of spacers were plasmid-derived, but on solid medium this dropped to ∼9%. Adjusting inducer concentration to match liquid conditions did not restore plasmid bias, indicating a physiological basis linked to colony growth. Accounting for the molar excess of chromosomal DNA, the 9% plasmid share reflects near-neutral DNA source sampling rather than plasmid overrepresentation. These findings suggest that the spatial and metabolic structure of colonies strongly shapes the adaptation landscape. The assay provides a scalable platform for dissecting condition-specific features of CRISPR-Cas adaptation, including spacer origin, sequence features, and growth context.

Indexed as

CRISPR-Cas SystemsDNA, IntergenicEscherichia coliAdaptation, PhysiologicalCRISPR-Associated ProteinsEscherichia coli ProteinsLac OperonPlasmidsCRISPR-Associated ProteinsDNA, IntergenicEscherichia coli Proteins

Identifiers

PMID41118570
PMCPMC12539621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.